No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline
Here's Why Agios Stock Plummeted More Than 20% on Monday
Improved Revenues Required Before CytomX Therapeutics, Inc. (NASDAQ:CTMX) Stock's 28% Jump Looks Justified
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround
CytomX Therapeutics Analyst Ratings